Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Divisón

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Semergen|July 3, 2016
[LDL-cholesterol targets arrive at the American guidelines]C Escobar, J A Divisón
Semergen|April 5, 2015
[Should beta blockers remain as first-line therapy in the treatment of patients with atrial fibrillation and heart failure?]C Escobar, J A Divisón
Semergen|April 26, 2015
[Loss of weight and diabetes]C Escobar, J A Divisón
Semergen|August 11, 2016
[New recommendations of 2016 European Guidelines on cardiovascular disease prevention]C Escobar, J A Divisón
Semergen|July 19, 2015
[Cardiovascular safety of DPP-4 inhibitors]C Escobar, J A Divisón
Semergen|September 28, 2016
[New recommendations of 2016 European Guidelines for the diagnosis and treatment of heart failure]C Escobar, J A Divisón
Semergen|April 28, 2016
[Cardiotoxicity. A reality that the primary care physician should be aware]C Escobar, J A Divisón
Semergen|February 25, 2016
[New evidence for the management of patients with heart failure with preserved ejection fraction]C Escobar, J A Divisón
Semergen|February 4, 2016
[Efficacy of percutaneous coronary intervention in patients with chronic ischaemic heart disease]C Escobar, J A Divisón
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 17, 2002
[Home self-measurement and ambulatory monitoring. Alternative and/or complementary techniques?]J A Divisón, L M Artigao
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Semergen|July 3, 2016
[LDL-cholesterol targets arrive at the American guidelines]C Escobar, J A Divisón
Semergen|April 5, 2015
[Should beta blockers remain as first-line therapy in the treatment of patients with atrial fibrillation and heart failure?]C Escobar, J A Divisón
Semergen|April 26, 2015
[Loss of weight and diabetes]C Escobar, J A Divisón
Semergen|August 11, 2016
[New recommendations of 2016 European Guidelines on cardiovascular disease prevention]C Escobar, J A Divisón
Semergen|July 19, 2015
[Cardiovascular safety of DPP-4 inhibitors]C Escobar, J A Divisón
Semergen|September 28, 2016
[New recommendations of 2016 European Guidelines for the diagnosis and treatment of heart failure]C Escobar, J A Divisón
Semergen|April 28, 2016
[Cardiotoxicity. A reality that the primary care physician should be aware]C Escobar, J A Divisón
Semergen|February 25, 2016
[New evidence for the management of patients with heart failure with preserved ejection fraction]C Escobar, J A Divisón
Semergen|February 4, 2016
[Efficacy of percutaneous coronary intervention in patients with chronic ischaemic heart disease]C Escobar, J A Divisón
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 17, 2002
[Home self-measurement and ambulatory monitoring. Alternative and/or complementary techniques?]J A Divisón, L M Artigao
Pageof 9